Ocean Biomedical, Inc. Common Stock
OCEA
OCEA was delisted on the 23rd of April, 2025.
7 hedge funds and large institutions have $5.69K invested in Ocean Biomedical, Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 20 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
72% less funds holding
Funds holding: 25 → 7 (-18)
90% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 20
98% less capital invested
Capital invested by funds: $247K → $5.69K (-$242K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$18.4K |
| 2 |
Vanguard Personalized Indexing Management
Oakland,
California
|
+$2.19K |
| 3 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
+$1.52K |
| 4 |
SMA
Sage Mountain Advisors
Atlanta,
Georgia
|
+$458 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$142K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$25.5K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$22K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$13.3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$8.73K |
OCEA Hedge Fund Activity: Q2 2025 in Review
7 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Ocean Biomedical, Inc. Common Stock (OCEA) for Q2 2025, worth a combined $5.69K — down 98% from $247K a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of OCEA and 2 opened new positions — a net loss of 18 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was XTX Topco, opening a new position worth an estimated $18.4K. The largest seller was Polar Asset Management Partners, exiting entirely with an estimated $142K sold.
- 7 institutional investors held Ocean Biomedical, Inc. Common Stock (OCEA) as of Q2 2025, down from 25 in Q1 2025.
- Funds reported $5.69K of Ocean Biomedical, Inc. Common Stock stock for Q2 2025, down 98% quarter-over-quarter.
- 2 funds opened new Ocean Biomedical, Inc. Common Stock positions in Q2 2025 and 20 closed out, a net change of -18 holders.
- The largest Ocean Biomedical, Inc. Common Stock buyer in Q2 2025 was XTX Topco, an estimated $18.4K added.
- The largest Ocean Biomedical, Inc. Common Stock seller in Q2 2025 was Polar Asset Management Partners, an estimated $142K sold.
Based on aggregated 13F filings for Q2 2025.